Patent · US Active

Immunogenic composition

US8883163B2 · kind B2 · utility

8Cited by

28References

18Claims

0Family size

Assignee

GLAXOSMITHKLINE BIOLOGICALS SA · BE

Inventors

Ralph Leon Biemans · Rixensart, BE
Dominique Boutriau · Rixensart, BE
Carine Capiau · Rixensart, BE
Philippe Denoel · Rixensart, BE
Pierre Duvivier · Rixensart, BE
Jan Poolman · Broek in Waterland, NL

Key dates

Filing date	Feb 27, 2013
Grant date	Nov 11, 2014
Priority date	—
Expiry date	Feb 27, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application discloses an immunogenic composition comprising a Hib saccharide conjugate, at least one additional bacterial, for example N. meningitidis, saccharide conjugate(s), and a further antigen selected from the group consisting of whole cell pertussis and hepatitis B surface antigen, wherein the saccharide dose of the Hib saccharide conjugate is less than 5 μg.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.